EntryPoint Capital’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-9,388	Closed	-$315K	–	652
2025 Q1	$315K	Buy	+9,388	New	+$315K	0.14%	295
2024 Q3	–	Sell	-2,845	Closed	-$127K	–	727
2024 Q2	$127K	Buy	+2,845	New	+$127K	0.19%	201